Navigation Links
Simpler Anemia Treatment May Help Kidney Patients
Date:10/19/2007

Newer drug is given just once per month, experts say

FRIDAY, Oct. 19 (HealthDay News) -- A new approach for treating anemia in patients with severe kidney disease could help improve patients' quality of life, according to a U.S. study.

Compared with conventional therapy, giving patients an anti-anemia drug as infrequently as once a month could simplify anemia management, concluded Dr. Nathan Levin, of the Renal Research Institute in New York, and colleagues.

The findings are published in the Oct. 20 issue of The Lancet.

Conventional therapy with epoetin (a synthetic form of human erythropoietin that promotes red blood cell production) requires frequent administrations (at least once weekly), changes of dose, and close monitoring of hemoglobin concentrations.

In this study involving patients on dialysis, the researchers compared the use of a long-acting erythropoieses-stimulating agent variant of epoetin (methoxy polyethylene glycol-epoetin beta) given intravenously at 2-week or 4-week intervals, with epoetin treatment one to three times per week.

All 673 patients in the study received conventional epoetin treatment for the first four weeks of the study. After that, one group of patients received methoxy polyethylene glycol-epoetin beta every two weeks, another group received methoxy polyethylene glycol-epoetin beta every four weeks, and the third group continued receiving conventional epoetin treatment.

After about 42 weeks, there were no statistically significant differences in hemoglobin concentrations between the three groups. Based on their findings, the researchers recommended that methoxy polyethylene glycol-epoetin beta be introduced as an option for simplified management of anemia in patients on dialysis.

However, the authors of an accompanying Comment article called for more research.

"Before we can concur on a precise clinical role for this molecule, we need to explore issues other than simply the non-inferiority with other epoetins to reach certain unvalidated surrogates. Different doses and molecular characteristics of epoetins may affect patient-level endpoints, independent of achieved hemoglobin. When these issues are examined, we might be truly confident that a newer molecule is non-inferior to existing ones," wrote Dr. Rowan Walker of the Royal Melbourne Hospital and Monash University Alfred Hospital in Melbourne, Australia, and Dr. Giovanni Strippoli, of the University of Sydney, Australia, and the Mario Negri Sud Consortium in Chieti, Italy.

More information

The U.S. National Institute on Diabetes and Digestive and Kidney Diseases has more about anemia.



-- Robert Preidt



SOURCE: The Lancet, news release, Oct. 19, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Surgeons Develop Simpler Way to Cure Atrial Fibrillation
2. Detection of Malignant Breast Tumors Made Simpler and More Effective
3. Liver Regeneration may Be Simpler Than Previously Thought
4. Fight anemia by fortifying crops with iron!!!!!!!!
5. Doctors advice early anemia tests
6. Anemia Treatment for Cancer Patients
7. Anemia Treatment for Cancer Patients
8. Anemia Treatment for Cancer Patients Might Not be a Good Idea.
9. Anemia may Lead to Physical Decline
10. Gene to identify risk of stroke in sickle cell anemia
11. New treatment for babies with sickle cell anemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... 26, 2017 , ... Six greater Bay Area roller derby leagues are partnering with Brown Paper ... widely attended series of blood drives in California, beginning July 29. Make ‘Em Bleed roller ... years -- enough to have helped to save up to 2700 lives. , “The Make ...
(Date:7/26/2017)... (PRWEB) , ... July 26, 2017 , ... A major ... processes. Inconsistent results freeze drying samples and a lengthy freeze dry cycle are a ... will discuss freeze drying techniques, as well as new accessories and advancements in laboratory ...
(Date:7/26/2017)... ... July 26, 2017 , ... “We are dentists and we thought there ... Jose, Calif., “so we invented the MAGNETIC/ LOCK BRACKETS.” , The patent-pending MAGNETIC/ LOCK ... In doing so, it offers an effective alternative to traditional braces. As a result, ...
(Date:7/26/2017)... ... ... to sign up for the new One-A-Month Essential Oil Club for fun and wellness. ... and author of numerous books on essential oils. , , Members ... Two items are included in the December mailing. , A HOW ...
(Date:7/26/2017)... ATLANTA, Ga. (PRWEB) , ... July 26, 2017 , ... ... and equal access to medicine for everyone affected by diabetes, is excited to announce ... of its Global Ambassador Program. , Established in 2005, the Team Type 1 ...
Breaking Medicine News(10 mins):
(Date:7/14/2017)... , July 14, 2017 Endo International plc (NASDAQ: ... on Tuesday, August 8, 2017.  Members of its senior management team ... markets open at 8:30 a.m. ET. The dial-in ... (866) 497-0462, International (678) 509-7598, and the passcode is 45397076. Please ... A replay of the call ...
(Date:7/12/2017)... , July 12, 2017 CarpalAID is a revolutionary ... braces or surgery. Carpal tunnel syndrome affects more than ... at twice the rate of men. The common methods of treating ... mobilization with uncomfortable hand braces or gloves. ... CarpalAID is a clear patch ...
(Date:7/11/2017)... , July 11, 2017  Sysmex America, Inc., ... diagnostic testing equipment as well as middleware information ... way to make quality assurance easier and more ... is well known for the innovation that it ... Monitor elevates quality assurance processes to a new ...
Breaking Medicine Technology: